NSE · ENTERO
Entero Healthcare Solutions Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹83 Cr with net profit ₹3 Cr — a 4.16% net margin, versus 1.74% the period before.
Shareholding
As of 2026-06-30
- Promoter52.4%
- Public27.75%
- FII4.37%
- DII15.48%
39,710 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.03× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ST-ASM · ASM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Trading · ranked #17 of 674 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹4,16,478 Cr | 161.79 | 4.4 | 3.93% | 6.78% |
| Avenue Supermarts Limited | ₹2,40,679 Cr | 78.69 | 9.84 | 12.14% | 4.29% |
| Trent Ltd. | ₹1,50,302 Cr | 82.2 | 21.52 | 24.62% | 8.64% |
| FSN E-Commerce Ventures Ltd. | ₹97,945 Cr | 367.69 | 68.12 | 13.87% | 2.41% |
| Vishal Mega Mart Limited | ₹48,441 Cr | 54.42 | 6.52 | 11.32% | 6.61% |
| Aegis Logistics Limited | ₹45,897 Cr | 36.68 | 7.58 | 14.83% | 13.95% |
| Aditya Infotech Limited | ₹45,298 Cr | 94.92 | 24.13 | 19.61% | 9.77% |
| Premier Energies Limited | ₹43,938 Cr | 26.39 | 10.2 | 35.05% | 19.67% |
| Redington Limited | ₹30,646 Cr | 17.04 | 3.02 | 14.67% | 1.33% |
| Honasa Consumer Limited | ₹15,507 Cr | 61.45 | 10.98 | 14.16% | 9.75% |
| Entero Healthcare Solutions Ltd.(this company) | ₹7,803 Cr | 60.08 | 4.64 | 6.81% | 1.76% |
AI analysis
AI-generated · google/gemini-2.5-flashEntero Healthcare Solutions Ltd. is listed with a market capitalization of Rs 5114 Cr. The company reported revenue of Rs 5135.29 Cr and an EPS of 24.69. The stock's 52-week high is 1390 and its 52-week low is 944.
Positives
- +The debt-to-equity ratio is 0.22, indicating a low level of debt.
- +Promoter holding of 52.4181% as of Mar 2026 suggests significant skin in the game.
- +Promoter pledge is 0%, indicating no shares are pledged.
Negatives
- −No annual EPS data is available for the periods Mar 2025, Jun 2025, Sept 2025, Dec 2025, and Mar 2026.
- −No quarterly EPS data is available for any period from Dec 2024 to Mar 2026.
- −FII shareholding decreased from 19.9198% in Mar 2025 to 4.0291% in Mar 2026.
Financial Performance
Entero Healthcare Solutions Ltd. reported total revenue of Rs 5135.29 Cr. The company's quarterly revenue has shown an increasing trend, rising from Rs 1359 Cr in Dec 2024 to Rs 1909.93 Cr in Mar 2026. Net profit also increased from Rs 25.44 Cr in Dec 2024 to Rs 28.01 Cr in Mar 2026, though with some fluctuations.
Profitability & Returns
The company's Return on Equity (ROE) stands at 6.3% and Return on Capital Employed (ROCE) is 9.74%. The Earnings Per Share (EPS) is 24.69. Quarterly EBITDA has shown growth, from Rs 49.41 Cr in Dec 2024 to Rs 75.26 Cr in Mar 2026.
Balance Sheet
Entero Healthcare Solutions Ltd. has a book value of 395.31. The debt-to-equity ratio is 0.22, indicating a relatively low level of debt compared to equity.
Ownership & Pledges
Promoter pledge is reported as 0%.
Regulatory & Surveillance
The company has not disclosed annual EPS data for the fiscal years Mar 2025, Jun 2025, Sept 2025, Dec 2025, or Mar 2026. Similarly, quarterly EPS data is not available for any reported quarter from Dec 2024 to Mar 2026.
Data as of — price: 2026-09-10 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Entero Healthcare Solutions Ltd.share price & fundamentals